Malvern-based Endo has approved $3.5 million in retention bonuses for its key executives as it works toward a merger with ...

Endo Inc. approved more than $3.5 million in retention bonuses for key executives, and that figure could grow, as it works to ...

Mallinckrodt and Endo are set to merge in a cash-and-stock deal valued at $6.7 billion, with the drug makers set to list shares of the new firm on the New York Stock Exchange.

Mallinckrodt PLC, the Irish pharmaceutical company with its U.S. headquarters in Hazelwood, has agreed to merge with drug maker Endo Inc. in a cash and stock transaction that values the combined ...

(RTTNews) - Specialty pharmaceutical companies Mallinckrodt plc and Endo, Inc. announced Thursday that they have entered into a definitive agreement to combine in a stock and cash transaction.

Mallinckrodt and Endo Pharmaceuticals, which have struggled through bankruptcies related to opioid litigation, said Thursday that they will merge in a cash and stock transaction that will leave a ...

Ireland’s Mallinckrodt will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion. The companies said Thursday that Endo shareholders will receive a total of $80 million in ...

(Reuters) -Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the matter told Reuters on Wednesday. A deal could likely be ...